地诺单抗在颞骨鳞状细胞复发性软骨母细胞瘤中的应用：一例报告
Use of denosumab in recurrent chondroblastoma of the squamous temporal bone: a case report.
作者信息
Calvert Nicholas, Wood David
机构信息
Department of Orthopaedic Surgery Sir Charles Gairdner Hospital Nedlands Western Australia 6009 Australia.
出版信息
Clin Case Rep. 2017 Feb 23;5(4):411-413. doi: 10.1002/ccr3.838. eCollection 2017 Apr.
Abstract
Chondroblastoma is a rare, benign bone tumor that represents 1-2% of all primary bone tumors. Denosumab, a monoclonal antibody, has been demonstrated to inhibit the growth of giant cell tumors. We report a case of recurrent chondroblastoma of the squamous temporal bone that is currently suppressed with denosumab.
摘要
软骨母细胞瘤是一种罕见的良性骨肿瘤，占所有原发性骨肿瘤的1%-2%。地诺单抗是一种单克隆抗体，已被证明可抑制巨细胞瘤的生长。我们报告一例颞骨鳞部复发性软骨母细胞瘤，目前用地诺单抗控制。
Zotero 插件